ELAPRASE (idursulfase) Solution for intravenous infusion

Elaprase is an IV infusion used to treat some of the symptoms of a genetic condition called Hunter’s syndrome, also called mucopolysaccharidosis . Idursulfase contains a natural enzyme that some people lack because of a genetic disorder. Elaprase helps replace this missing enzyme. Brand Name: ELAPRASE (idursulfase) Solution for intravenous infusion

Home | (idursulfase) Solution

ELAPRASE (idursulfase) Solution Price In India and Overseas
ELAPRASE (idursulfase) Solution

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

ELAPRASE (idursulfase) Solution

Idursulfase is indicated for patients with Hunter syndrome (Mucopolysaccharidosis II, MPS II). ELAPRASE has been shown to improve walking capacity in these patients.

ELAPRASE is a formulation of idursulfase, a purified form of human iduronate-2-sulfatase, a lysosomal enzyme. Idursulfase is produced by recombinant DNA technology in a human cell line. Idursulfase is an enzyme that hydrolyzes the 2-sulfate esters of terminal iduronate sulfate residues from the glycosaminoglycans dermatan sulfate and heparan sulfate in the lysosomes of various cell types.

Idursulfase is a drug used to treat Hunter syndrome (also called MPS-II). It is a purified form of the lysosomal enzyme iduronate-2-sulfatase and is produced by recombinant DNA technology in a human cell line.

Drug (Brand / Generic): ELAPRASE / idursulfase
Current Indications: Hunter syndrome (Mucopolysaccharidosis II, MPS II)
Marketed by:: Shire plc
Approval Date: First approved July 24, 2006

Dosage forms and strengths of ELAPRASE (idursulfase).
Each vial contains an extractable volume of 3.0 mL with an idursulfase concentration of 2.0 mg/mL.

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.